Fosså SD - Search Results

1

Serum follicle stimulating hormone--predictor of cancer in the remaining testis in patients with unilateral testicular cancer.

Wanderas EH, Fosså SD, Heilo A, Stenwig AE, Norman N. Wanderas EH, et al. Among authors: fossa sd. Br J Urol. 1990 Sep;66(3):315-7. doi: 10.1111/j.1464-410x.1990.tb14935.x. Br J Urol. 1990. PMID: 2119845

2

Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?

Fosså SD, Qvist H, Stenwig AE, Lien HH, Ous S, Giercksky KE. Fosså SD, et al. J Clin Oncol. 1992 Apr;10(4):569-73. doi: 10.1200/JCO.1992.10.4.569. J Clin Oncol. 1992. PMID: 1312586

3

Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatment.

Fosså SD, Paus E, Lindegaard M, Newling DW. Fosså SD, et al. Br J Urol. 1992 Feb;69(2):175-9. doi: 10.1111/j.1464-410x.1992.tb15491.x. Br J Urol. 1992. PMID: 1371425

4

The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.

Fosså SD, Waehre H, Paus E. Fosså SD, et al. Br J Cancer. 1992 Jul;66(1):181-4. doi: 10.1038/bjc.1992.239. Br J Cancer. 1992. PMID: 1379059 Free PMC article.

5

Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.

Waehre H, Wanderaas EH, Paus E, Fosså SD. Waehre H, et al. Among authors: fossa sd. Eur Urol. 1992;22(1):33-8. doi: 10.1159/000474718. Eur Urol. 1992. PMID: 1385143

6

Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party).

Fosså SD, Harland SJ, Kaye SB, Raghavan D, Russell JM, Parmar MK, Uscinska BM, Wood R. Fosså SD, et al. Br J Urol. 1992 Aug;70(2):161-8. doi: 10.1111/j.1464-410x.1992.tb15696.x. Br J Urol. 1992. PMID: 1393439 Clinical Trial.

7

DNA flow cytometry and neo-adjuvant chemotherapy/radiotherapy in operable muscle-invasive bladder carcinoma. A preliminary report.

Jacobsen AB, Berner A, Juul M, Ous S, Pettersen EO, Fosså SD. Jacobsen AB, et al. Among authors: fossa sd. Eur Urol. 1992;22(4):316-22. doi: 10.1159/000474779. Eur Urol. 1992. PMID: 1490510

8

Deoxyribonucleic acid cytometry and histological findings before and after 125iodine implantation of primary prostate cancer.

Waehre H, Amellem O, Stenwig AE, Tverå K, Juul M, Pettersen EO, Fosså SD. Waehre H, et al. Among authors: fossa sd. J Urol. 1992 Sep;148(3):838-41; discussion 841-2. doi: 10.1016/s0022-5347(17)36737-x. J Urol. 1992. PMID: 1512835

9

Cisplatin and 5-fluorouracil in advanced cancer of the penis.

Shammas FV, Ous S, Fossa SD. Shammas FV, et al. Among authors: fossa sd. J Urol. 1992 Mar;147(3):630-2. doi: 10.1016/s0022-5347(17)37327-5. J Urol. 1992. PMID: 1538445

10

Retroperitoneal surgery in patients with nonseminomatous testicular cancer and minimal residual tumor.

Qvist H, Fosså SD, Ous S, Lien HH, Stenwig AE, Giercksky KE. Qvist H, et al. Among authors: fossa sd. J Surg Oncol. 1992 Aug;50(4):220-3. doi: 10.1002/jso.2930500404. J Surg Oncol. 1992. PMID: 1640703

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

934 results

Search Page